← Open Payments lookup

ALBERT STONE: Open Payments

NPI 1659852150 · ROOSEVELT, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$246 in 12 payments from 8 companies in 2025. Trend: 2023 $441 · 2024 $467 · 2025 $246

Food & beverage: $246
CompanyPaymentsAmount
GlaxoSmithKline, LLC.3$62
Amgen Inc.2$53
Novartis Pharmaceuticals Corporation2$40
Genentech USA, Inc.1$26
E.R. Squibb & Sons, L.L.C.1$18
Merck Sharp & Dohme LLC1$17
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16
VERTEX PHARMACEUTICALS INCORPORATED1$14

Products named: BENLYSTA, COSENTYX, EVENITY, Actemra, ENBREL, ORENCIA, VERQUVO, CAPLYTA.

Industry payments across UT — which companies pay providers there.